Portfolio Holdings Detail for ISIN IE00BYXG2H39
Stock Name / Fund iShares Nasdaq US Biotechnology UCITS ETF USD (Acc)
Issuer Blackrock
Entity holding fund iShares IV Public Limited Company
Entity Type Umbrella investment company with variable capital and having segregated liability between its funds
Entity LEI 549300ZP07LMR36K1T02
ETF Ticker BTEC(USD) LSE
ETF Ticker BTEK(GBP) LSE
ETF Ticker 2B70(EUR) F
ETF Ticker 2B70.DE(EUR) CXE
ETF Ticker BTEC.LS(USD) CXE
ETF Ticker BTEK.LS(GBP) CXE
ETF Ticker BTEC.L(GBP) LSE
ETF Ticker BTEK.L(GBP) LSE

Holdings detail for ZYME

Stock Name	Zymeworks Inc. Common Stock
Ticker	ZYME(USD) NASDAQ
TYPE	Common Stock
Country	USA
ISIN	CA98985W1023

Show aggregate ZYME holdings

News associated with ZYME

Analysts Predict 13% Gains Ahead For ISCG: Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-09-19 08:09:20
Citigroup Increases Zymeworks (NYSE:ZYME) Price Target to $22.00: Zymeworks (NYSE:ZYME – Get Free Report) had its price objective hoisted by Citigroup from $19.00 to $22.00 in a research report issued to clients and investors on Monday,Benzinga reports. The firm currently has a “buy” rating on the stock. Citigroup’s target price points to a potential upside of 68.97% from the stock’s previous close. A […] - 2025-08-13 02:46:43
Zymeworks (NASDAQ:ZYME) Downgraded to Hold Rating by Wall Street Zen: Zymeworks (NASDAQ:ZYME – Get Free Report) was downgraded by research analysts at Wall Street Zen from a “buy” rating to a “hold” rating in a research note issued on Saturday. Zymeworks Price Performance Shares of ZYME stock opened at $12.02 on Friday. The stock has a market cap of $837.55 million, a P/E ratio of […] - 2025-08-11 02:58:46
Cwm LLC Increases Stock Holdings in Zymeworks Inc. (NYSE:ZYME): Cwm LLC increased its holdings in Zymeworks Inc. (NYSE:ZYME – Free Report) by 1,091.2% in the first quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 2,299 shares of the company’s stock after acquiring an additional 2,106 shares during the quarter. Cwm LLC’s holdings in Zymeworks […] - 2025-08-06 04:27:03
Zymeworks Inc. (NYSE:ZYME) Receives $21.00 Average Price Target from Analysts: Zymeworks Inc. (NYSE:ZYME – Get Free Report) has been given a consensus recommendation of “Moderate Buy” by the ten brokerages that are currently covering the stock, Marketbeat.com reports. Two investment analysts have rated the stock with a hold recommendation, seven have given a buy recommendation and one has assigned a strong buy recommendation to the […] - 2025-06-24 02:16:45
Ritholtz Wealth Management Decreases Holdings in Zymeworks Inc. (NYSE:ZYME): Ritholtz Wealth Management lessened its stake in shares of Zymeworks Inc. (NYSE:ZYME – Free Report) by 18.8% in the first quarter, HoldingsChannel.com reports. The institutional investor owned 60,494 shares of the company’s stock after selling 13,972 shares during the quarter. Ritholtz Wealth Management’s holdings in Zymeworks were worth $720,000 as of its most recent filing […] - 2025-06-19 05:00:55
Assenagon Asset Management S.A. Sells 147,184 Shares of Zymeworks Inc. (NYSE:ZYME): Assenagon Asset Management S.A. cut its position in shares of Zymeworks Inc. (NYSE:ZYME – Free Report) by 22.9% during the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 495,067 shares of the company’s stock after selling 147,184 shares during the quarter. Assenagon Asset Management S.A. […] - 2025-06-15 05:44:57
Public Employees Retirement System of Ohio Sells 10,400 Shares of Zymeworks Inc. (NYSE:ZYME): Public Employees Retirement System of Ohio lessened its stake in shares of Zymeworks Inc. (NYSE:ZYME – Free Report) by 17.1% in the 4th quarter, HoldingsChannel.com reports. The fund owned 50,583 shares of the company’s stock after selling 10,400 shares during the period. Public Employees Retirement System of Ohio’s holdings in Zymeworks were worth $741,000 as […] - 2025-06-04 04:56:48
Nuveen Asset Management LLC Increases Stock Holdings in Zymeworks Inc. (NYSE:ZYME): Nuveen Asset Management LLC boosted its stake in Zymeworks Inc. (NYSE:ZYME – Free Report) by 0.4% during the fourth quarter, Holdings Channel.com reports. The institutional investor owned 207,023 shares of the company’s stock after acquiring an additional 886 shares during the period. Nuveen Asset Management LLC’s holdings in Zymeworks were worth $3,031,000 at the end […] - 2025-06-03 04:53:06
Analysts Set Zymeworks Inc. (NYSE:ZYME) Target Price at $21.00: Shares of Zymeworks Inc. (NYSE:ZYME – Get Free Report) have received an average rating of “Moderate Buy” from the ten research firms that are covering the company, Marketbeat.com reports. Two investment analysts have rated the stock with a hold recommendation, seven have issued a buy recommendation and one has assigned a strong buy recommendation to […] - 2025-05-30 03:06:52
Zymeworks (NYSE:ZYME) Stock Price Up 4.2% After Insider Buying Activity: Shares of Zymeworks Inc. (NYSE:ZYME – Get Free Report) shot up 4.2% during trading on Tuesday after an insider bought additional shares in the company. The company traded as high as $12.22 and last traded at $12.32. 24,363 shares traded hands during trading, a decline of 96% from the average session volume of 596,591 shares. […] - 2025-05-22 02:32:57
Schonfeld Strategic Advisors LLC Invests $334,000 in Zymeworks Inc. (NYSE:ZYME): Schonfeld Strategic Advisors LLC purchased a new stake in Zymeworks Inc. (NYSE:ZYME – Free Report) in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 22,800 shares of the company’s stock, valued at approximately $334,000. A number of other […] - 2025-05-13 04:44:53
Barclays PLC Purchases 66,506 Shares of Zymeworks Inc. (NYSE:ZYME): Barclays PLC raised its position in Zymeworks Inc. (NYSE:ZYME – Free Report) by 43.1% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 220,890 shares of the company’s stock after purchasing an additional 66,506 shares during the quarter. Barclays PLC’s holdings in Zymeworks […] - 2025-04-29 05:22:53
Legal & General Group Plc Acquires 2,590 Shares of Zymeworks Inc. (NYSE:ZYME): Legal & General Group Plc increased its holdings in Zymeworks Inc. (NYSE:ZYME – Free Report) by 5.8% in the 4th quarter, according to its most recent filing with the SEC. The institutional investor owned 47,082 shares of the company’s stock after buying an additional 2,590 shares during the quarter. Legal & General Group Plc’s holdings […] - 2025-04-29 04:50:50
Russell Investments Group Ltd. Cuts Stake in Zymeworks Inc. (NYSE:ZYME): Russell Investments Group Ltd. reduced its holdings in shares of Zymeworks Inc. (NYSE:ZYME – Free Report) by 9.7% during the fourth quarter, Holdings Channel reports. The fund owned 44,945 shares of the company’s stock after selling 4,826 shares during the period. Russell Investments Group Ltd.’s holdings in Zymeworks were worth $658,000 at the end of […] - 2025-04-23 05:20:54
Geode Capital Management LLC Reduces Stock Position in Zymeworks Inc. (NYSE:ZYME): Geode Capital Management LLC trimmed its holdings in shares of Zymeworks Inc. (NYSE:ZYME – Free Report) by 3.4% in the fourth quarter, Holdings Channel reports. The institutional investor owned 689,884 shares of the company’s stock after selling 24,031 shares during the period. Geode Capital Management LLC’s holdings in Zymeworks were worth $10,100,000 as of its […] - 2025-04-23 04:27:03
Renaissance Technologies LLC Increases Stock Holdings in Zymeworks Inc. (NYSE:ZYME): Renaissance Technologies LLC increased its holdings in shares of Zymeworks Inc. (NYSE:ZYME – Free Report) by 54.8% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 285,700 shares of the company’s stock after buying an additional 101,100 shares during the quarter. Renaissance Technologies […] - 2025-04-22 05:04:52
XTX Topco Ltd Invests $493,000 in Zymeworks Inc. (NYSE:ZYME): XTX Topco Ltd acquired a new position in shares of Zymeworks Inc. (NYSE:ZYME – Free Report) in the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor acquired 33,702 shares of the company’s stock, valued at approximately $493,000. Other hedge funds have also made changes to their positions in the […] - 2025-04-21 05:44:47
Federated Hermes Inc. Has $2.66 Million Holdings in Zymeworks Inc. (NYSE:ZYME): Federated Hermes Inc. grew its holdings in Zymeworks Inc. (NYSE:ZYME – Free Report) by 1.9% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 181,626 shares of the company’s stock after buying an additional 3,367 shares during the period. Federated […] - 2025-04-14 05:15:00
Zymeworks Inc. (NYSE:ZYME) Director Ecor1 Capital, Llc Purchases 196,438 Shares: Zymeworks Inc. (NYSE:ZYME – Get Free Report) Director Ecor1 Capital, Llc purchased 196,438 shares of the firm’s stock in a transaction that occurred on Friday, April 4th. The stock was acquired at an average price of $11.17 per share, with a total value of $2,194,212.46. Following the completion of the purchase, the director now owns […] - 2025-04-09 05:05:20
Zymeworks Inc. (NYSE:ZYME) Given Average Rating of “Moderate Buy” by Brokerages: Shares of Zymeworks Inc. (NYSE:ZYME – Get Free Report) have received a consensus recommendation of “Moderate Buy” from the eight ratings firms that are presently covering the firm, Marketbeat.com reports. Two analysts have rated the stock with a hold rating, five have assigned a buy rating and one has issued a strong buy rating on […] - 2025-04-07 03:06:59
Schroder Investment Management Group Acquires New Shares in Zymeworks Inc. (NYSE:ZYME): Schroder Investment Management Group bought a new position in Zymeworks Inc. (NYSE:ZYME – Free Report) in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The firm bought 337,161 shares of the company’s stock, valued at approximately $4,892,000. A number of other hedge funds have also added to […] - 2025-04-06 05:29:07
Zymeworks (NYSE:ZYME) Coverage Initiated by Analysts at Lifesci Capital: Lifesci Capital initiated coverage on shares of Zymeworks (NYSE:ZYME – Free Report) in a research note published on Tuesday,Benzinga reports. The brokerage issued an outperform rating and a $30.00 target price on the stock. A number of other research analysts have also recently commented on ZYME. JPMorgan Chase & Co. upgraded Zymeworks from a “neutral” […] - 2025-03-12 05:08:49
HC Wainwright Issues Positive Forecast for Zymeworks (NYSE:ZYME) Stock Price: Zymeworks (NYSE:ZYME – Free Report) had its target price raised by HC Wainwright from $12.00 to $13.00 in a research note issued to investors on Monday,Benzinga reports. HC Wainwright currently has a neutral rating on the stock. ZYME has been the topic of several other research reports. Wells Fargo & Company raised their price target […] - 2025-03-11 04:02:50
Citigroup Forecasts Strong Price Appreciation for Zymeworks (NYSE:ZYME) Stock: Zymeworks (NYSE:ZYME – Free Report) had its target price raised by Citigroup from $18.00 to $19.00 in a report released on Friday morning,Benzinga reports. Citigroup currently has a buy rating on the stock. A number of other research firms have also weighed in on ZYME. Wells Fargo & Company raised their target price on Zymeworks […] - 2025-03-10 04:44:48
New York State Common Retirement Fund Purchases 4,000 Shares of Zymeworks Inc. (NYSE:ZYME): New York State Common Retirement Fund lifted its position in Zymeworks Inc. (NYSE:ZYME – Free Report) by 42.7% during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 13,371 shares of the company’s stock after buying an additional 4,000 shares during the period. […] - 2025-03-06 08:19:23
Zymeworks Inc. (NYSE:ZYME) Receives Consensus Recommendation of “Moderate Buy” from Brokerages: Zymeworks Inc. (NYSE:ZYME – Get Free Report) has been given a consensus rating of “Moderate Buy” by the seven research firms that are currently covering the stock, Marketbeat reports. Two equities research analysts have rated the stock with a hold recommendation, four have given a buy recommendation and one has assigned a strong buy recommendation […] - 2025-02-21 05:10:59

iShares Nasdaq US Biotechnology UCITS ETF USD (Acc) ZYME holdings

Date	Number of ZYME Shares Held	Base Market Value of ZYME Shares	Local Market Value of ZYME Shares	Change in ZYME Shares Held	Change in ZYME Base Value	Current Price per ZYME Share Held	Previous Price per ZYME Share Held
2025-12-03 (Wednesday)	53,776	USD 1,410,007	USD 1,410,007	0	USD 60,229	USD 26.22	USD 25.1
2025-12-02 (Tuesday)	53,776	USD 1,349,778	USD 1,349,778	1,920	USD -34	USD 25.1	USD 26.03
2025-12-01 (Monday)	51,856	USD 1,349,812	USD 1,349,812	0	USD -35,262	USD 26.03	USD 26.71
2025-11-28 (Friday)	51,856	USD 1,385,074	USD 1,385,074	128	USD -28,652	USD 26.71	USD 27.33
2025-11-27 (Thursday)	51,728	USD 1,413,726	USD 1,413,726	0	USD 0	USD 27.33	USD 27.33
2025-11-26 (Wednesday)	51,728	USD 1,413,726	USD 1,413,726	384	USD 69,540	USD 27.33	USD 26.18
2025-11-25 (Tuesday)	51,344	USD 1,344,186	USD 1,344,186	640	USD 77,093	USD 26.18	USD 24.99
2025-11-24 (Monday)	50,704	USD 1,267,093	USD 1,267,093	128	USD 52,257	USD 24.99	USD 24.02
2025-11-21 (Friday)	50,576	USD 1,214,836	USD 1,214,836	0	USD 10,116	USD 24.02	USD 23.82
2025-11-20 (Thursday)	50,576	USD 1,204,720	USD 1,204,720	-512	USD 50,131	USD 23.82	USD 22.6
2025-11-19 (Wednesday)	51,088	USD 1,154,589	USD 1,154,589	128	USD -16,981	USD 22.6	USD 22.99
2025-11-18 (Tuesday)	50,960	USD 1,171,570	USD 1,171,570	1,024	USD -21,900	USD 22.99	USD 23.9
2025-11-17 (Monday)	49,936	USD 1,193,470	USD 1,193,470	0	USD 268,655	USD 23.9	USD 18.52

Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of ZYME by Blackrock for IE00BYXG2H39

Show aggregate share trades of ZYME

Date Action Quantity Market High Market Low Likely Trade Price Likely Trade Value (Profit/Loss) Average Price previous trades
2025-12-02 BUY 1,920 25.100* 14.48
2025-11-28 BUY 128 26.710* 14.37
2025-11-26 BUY 384 27.330* 14.25
2025-11-25 BUY 640 26.180* 14.19
2025-11-24 BUY 128 24.990* 14.14
2025-11-20 SELL -512 23.820* 14.04 Profit of 7,190 on sale
2025-11-19 BUY 128 22.600* 14.00
2025-11-18 BUY 1,024 22.990* 13.96
2025-11-14 BUY 128 18.520* 13.88
2025-11-12 BUY 128 19.370* 13.83
2025-11-10 BUY 127 18.050* 13.78
2025-11-06 BUY 127 17.900* 13.75
2025-11-04 BUY 128 18.160* 13.70
2025-10-30 BUY 640 19.980 18.865 18.976 USD 12,145 13.62
2025-10-29 BUY 256 19.380 19.410 19.407 USD 4,968 13.59
2025-10-22 SELL -512 17.670 18.110 18.066 USD -9,250 13.47 Loss of -2,354 on sale
2025-10-20 BUY 256 18.320 19.100 19.022 USD 4,870 13.42
2025-10-17 BUY 639 18.400 18.567 18.550 USD 11,854 13.39
2025-10-15 BUY 1,016 18.620 18.690 18.683 USD 18,982 13.36
2025-10-03 BUY 861 16.940 17.210 17.183 USD 14,795 13.31
2025-10-02 BUY 123 16.900 17.180 17.152 USD 2,110 13.29
2025-09-30 BUY 246 17.080 17.390 17.359 USD 4,270 13.25
2025-09-26 BUY 246 16.600 16.660 16.654 USD 4,097 13.21
2025-09-25 BUY 246 16.160 16.200 16.196 USD 3,984 13.19
2025-09-24 BUY 1 16.300 16.610 16.579 USD 17 13.17
2025-09-18 BUY 123 16.490 16.595 16.584 USD 2,040 13.15
2025-09-17 BUY 372 15.870 16.555 16.487 USD 6,133 13.14
2025-08-20 SELL -492 14.320 14.340 14.338 USD -7,054 13.10 Loss of -610 on sale
2025-07-30 BUY 488 12.940 13.795 13.710 USD 6,690 13.08
2025-07-17 SELL -244 14.480 15.000 14.948 USD -3,647 13.03 Loss of -468 on sale
2025-07-11 SELL -984 13.340 13.800 13.754 USD -13,534 13.02 Loss of -720 on sale
2025-07-07 BUY 369 13.080 13.110 13.107 USD 4,836 13.01
2025-07-02 BUY 6,765 12.890 12.950 12.944 USD 87,566 13.01
2025-06-20 BUY 2,163 12.480 12.670 12.651 USD 27,364 13.02
2025-06-11 BUY 232 12.880 13.220 13.186 USD 3,059 13.04
2025-06-10 BUY 232 13.070 13.300 13.277 USD 3,080 13.04
2025-06-04 SELL -116 12.200 12.570 12.533 USD -1,454 13.06 Profit of 61 on sale
2025-04-23 BUY 116 12.450 12.930 12.882 USD 1,494 13.40
2025-04-10 SELL -928 9.440 9.800 9.764 USD -9,061 13.63 Profit of 3,584 on sale
2025-04-08 SELL -116 9.910 11.095 10.977 USD -1,273 13.71 Profit of 317 on sale
2025-04-07 SELL -116 10.430 10.745 10.713 USD -1,243 13.75 Profit of 352 on sale
2025-04-04 SELL -580 10.950 11.750 11.670 USD -6,769 13.78 Profit of 1,225 on sale
2025-04-01 BUY 476 11.620 12.050 12.007 USD 5,715 13.83
2025-03-31 SELL -348 11.910 12.095 12.077 USD -4,203 13.85 Profit of 618 on sale
2025-03-21 BUY 1,970 12.720 13.030 12.999 USD 25,608 13.95
2025-03-14 SELL -1,776 12.250 13.170 13.078 USD -23,227 14.05 Profit of 1,720 on sale
2025-03-07 SELL -220 12.000 12.210 12.189 USD -2,682 14.21 Profit of 444 on sale
2025-03-04 SELL -110 12.750 12.970 12.948 USD -1,424 14.28 Profit of 146 on sale
2025-02-25 BUY 220 13.570 14.040 13.993 USD 3,078 14.36
2025-02-19 SELL -110 14.820 14.820 14.820 USD -1,630 14.36 Loss of -50 on sale
2025-02-13 BUY 327 14.620 14.690 14.683 USD 4,801 14.32
2025-02-12 BUY 109 14.300 14.340 14.336 USD 1,563 14.32
2025-02-11 BUY 436 13.250 14.090 14.006 USD 6,107 14.35
2024-12-30 SELL -5,472 14.510 14.680 14.663 USD -80,236 14.23 Loss of -2,346 on sale
2024-11-18 SELL -1,860 14.910 15.405 15.355 USD -28,561 14.31 Loss of -1,953 on sale
2024-11-08 SELL -124 16.630 16.950 16.918 USD -2,098 13.92 Loss of -372 on sale
2024-10-21 SELL -126 13.170 13.480 13.449 USD -1,695 0.00 Loss of -1,695 on sale
Market high and low price is on the date.

Date	Action	Quantity	Market High	Market Low	Likely Trade Price	Likely Trade Value (Profit/Loss)	Average Price previous trades
2025-12-02	BUY	1,920			25.100*		14.48
2025-11-28	BUY	128			26.710*		14.37
2025-11-26	BUY	384			27.330*		14.25
2025-11-25	BUY	640			26.180*		14.19
2025-11-24	BUY	128			24.990*		14.14
2025-11-20	SELL	-512			23.820*		14.04 Profit of 7,190 on sale
2025-11-19	BUY	128			22.600*		14.00
2025-11-18	BUY	1,024			22.990*		13.96
2025-11-14	BUY	128			18.520*		13.88
2025-11-12	BUY	128			19.370*		13.83
2025-11-10	BUY	127			18.050*		13.78
2025-11-06	BUY	127			17.900*		13.75
2025-11-04	BUY	128			18.160*		13.70
2025-10-30	BUY	640	19.980	18.865	18.976	USD 12,145	13.62
2025-10-29	BUY	256	19.380	19.410	19.407	USD 4,968	13.59
2025-10-22	SELL	-512	17.670	18.110	18.066	USD -9,250	13.47 Loss of -2,354 on sale
2025-10-20	BUY	256	18.320	19.100	19.022	USD 4,870	13.42
2025-10-17	BUY	639	18.400	18.567	18.550	USD 11,854	13.39
2025-10-15	BUY	1,016	18.620	18.690	18.683	USD 18,982	13.36
2025-10-03	BUY	861	16.940	17.210	17.183	USD 14,795	13.31
2025-10-02	BUY	123	16.900	17.180	17.152	USD 2,110	13.29
2025-09-30	BUY	246	17.080	17.390	17.359	USD 4,270	13.25
2025-09-26	BUY	246	16.600	16.660	16.654	USD 4,097	13.21
2025-09-25	BUY	246	16.160	16.200	16.196	USD 3,984	13.19
2025-09-24	BUY	1	16.300	16.610	16.579	USD 17	13.17
2025-09-18	BUY	123	16.490	16.595	16.584	USD 2,040	13.15
2025-09-17	BUY	372	15.870	16.555	16.487	USD 6,133	13.14
2025-08-20	SELL	-492	14.320	14.340	14.338	USD -7,054	13.10 Loss of -610 on sale
2025-07-30	BUY	488	12.940	13.795	13.710	USD 6,690	13.08
2025-07-17	SELL	-244	14.480	15.000	14.948	USD -3,647	13.03 Loss of -468 on sale
2025-07-11	SELL	-984	13.340	13.800	13.754	USD -13,534	13.02 Loss of -720 on sale
2025-07-07	BUY	369	13.080	13.110	13.107	USD 4,836	13.01
2025-07-02	BUY	6,765	12.890	12.950	12.944	USD 87,566	13.01
2025-06-20	BUY	2,163	12.480	12.670	12.651	USD 27,364	13.02
2025-06-11	BUY	232	12.880	13.220	13.186	USD 3,059	13.04
2025-06-10	BUY	232	13.070	13.300	13.277	USD 3,080	13.04
2025-06-04	SELL	-116	12.200	12.570	12.533	USD -1,454	13.06 Profit of 61 on sale
2025-04-23	BUY	116	12.450	12.930	12.882	USD 1,494	13.40
2025-04-10	SELL	-928	9.440	9.800	9.764	USD -9,061	13.63 Profit of 3,584 on sale
2025-04-08	SELL	-116	9.910	11.095	10.977	USD -1,273	13.71 Profit of 317 on sale
2025-04-07	SELL	-116	10.430	10.745	10.713	USD -1,243	13.75 Profit of 352 on sale
2025-04-04	SELL	-580	10.950	11.750	11.670	USD -6,769	13.78 Profit of 1,225 on sale
2025-04-01	BUY	476	11.620	12.050	12.007	USD 5,715	13.83
2025-03-31	SELL	-348	11.910	12.095	12.077	USD -4,203	13.85 Profit of 618 on sale
2025-03-21	BUY	1,970	12.720	13.030	12.999	USD 25,608	13.95
2025-03-14	SELL	-1,776	12.250	13.170	13.078	USD -23,227	14.05 Profit of 1,720 on sale
2025-03-07	SELL	-220	12.000	12.210	12.189	USD -2,682	14.21 Profit of 444 on sale
2025-03-04	SELL	-110	12.750	12.970	12.948	USD -1,424	14.28 Profit of 146 on sale
2025-02-25	BUY	220	13.570	14.040	13.993	USD 3,078	14.36
2025-02-19	SELL	-110	14.820	14.820	14.820	USD -1,630	14.36 Loss of -50 on sale
2025-02-13	BUY	327	14.620	14.690	14.683	USD 4,801	14.32
2025-02-12	BUY	109	14.300	14.340	14.336	USD 1,563	14.32
2025-02-11	BUY	436	13.250	14.090	14.006	USD 6,107	14.35
2024-12-30	SELL	-5,472	14.510	14.680	14.663	USD -80,236	14.23 Loss of -2,346 on sale
2024-11-18	SELL	-1,860	14.910	15.405	15.355	USD -28,561	14.31 Loss of -1,953 on sale
2024-11-08	SELL	-124	16.630	16.950	16.918	USD -2,098	13.92 Loss of -372 on sale
2024-10-21	SELL	-126	13.170	13.480	13.449	USD -1,695	0.00 Loss of -1,695 on sale

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of ZYME

Date	Shorted Volume	Short Exempt Volume	Total Shares Traded	% Shorted
2025-09-19	94,136	1,600	239,515	39.3%
2025-09-18	87,507	0	276,415	31.7%
2025-09-17	78,917	12	185,265	42.6%
2025-09-16	48,268	0	96,783	49.9%
2025-09-15	91,077	30	160,435	56.8%
2025-09-12	52,048	0	124,347	41.9%
2025-09-11	100,668	0	235,025	42.8%
2025-09-10	58,604	0	142,916	41.0%
2025-09-09	69,135	0	136,587	50.6%
2025-09-08	62,729	0	164,403	38.2%
2025-09-05	64,229	0	206,255	31.1%
2025-09-04	67,077	0	153,481	43.7%
2025-09-03	57,275	0	125,689	45.6%
2025-09-02	105,513	0	205,869	51.3%
2025-08-29	53,363	0	90,353	59.1%
2025-08-28	62,796	200	117,564	53.4%
2025-08-27	39,838	0	64,384	61.9%
2025-08-26	50,535	0	78,631	64.3%
2025-08-25	50,376	205	104,856	48.0%
2025-08-22	52,901	0	140,092	37.8%
2025-08-21	42,417	0	92,901	45.7%
2025-08-20	37,914	505	63,656	59.6%
2025-08-19	63,172	0	111,574	56.6%
2025-08-18	72,639	0	124,538	58.3%
2025-08-15	50,490	0	105,800	47.7%
2025-08-14	74,408	595	141,373	52.6%
2025-08-13	116,112	0	237,707	48.8%
2025-08-12	65,345	0	134,908	48.4%
2025-08-11	75,572	0	170,921	44.2%
2025-08-08	105,315	0	506,942	20.8%
2025-08-07	60,083	0	127,816	47.0%
2025-08-06	225,620	900	359,568	62.7%
2025-08-05	54,397	0	121,221	44.9%
2025-08-04	39,683	0	90,919	43.6%
2025-08-01	40,790	0	376,657	10.8%
2025-07-31	21,115	0	71,774	29.4%
2025-07-30	65,554	0	129,960	50.4%
2025-07-29	51,677	0	112,921	45.8%
2025-07-28	59,981	0	107,253	55.9%
2025-07-25	35,014	0	82,719	42.3%
2025-07-24	60,894	0	104,765	58.1%
2025-07-23	39,590	45	68,976	57.4%
2025-07-22	71,302	0	128,676	55.4%
2025-07-21	81,357	0	133,962	60.7%
2025-07-18	77,153	20	152,213	50.7%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Note: All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability.

Stock Name / Fund	iShares Nasdaq US Biotechnology UCITS ETF USD (Acc)
Issuer	Blackrock
Entity holding fund	iShares IV Public Limited Company
Entity Type	Umbrella investment company with variable capital and having segregated liability between its funds
Entity LEI	549300ZP07LMR36K1T02
ETF Ticker	BTEC(USD) LSE
ETF Ticker	BTEK(GBP) LSE
ETF Ticker	2B70(EUR) F
ETF Ticker	2B70.DE(EUR) CXE
ETF Ticker	BTEC.LS(USD) CXE
ETF Ticker	BTEK.LS(GBP) CXE
ETF Ticker	BTEC.L(GBP) LSE
ETF Ticker	BTEK.L(GBP) LSE